PICOQUANT INNOVATIONS GMBH

Their core work

PicoQuant Innovations GmbH is a Berlin-based photonics instrumentation company specializing in time-resolved fluorescence measurements, single-photon detection, and pulsed laser systems. In H2020 projects, they contributed as an industrial partner in Marie Curie training networks, providing PhD students with hands-on access to precision optical instruments and expertise in biomedical imaging applications. Their core commercial offering centers on time-correlated single-photon counting (TCSPC) systems and related optical measurement hardware used in life sciences, neuroscience, and advanced microscopy. As an SME, they bridge the gap between high-precision photonics instrumentation and applied biomedical research.

What they specialise in

How they've shifted over time

Both of PicoQuant's H2020 projects started within one year of each other (2015–2016) and both concluded in 2019, so the dataset captures a single coherent period rather than a trajectory across two distinct phases. No keyword metadata was recorded for either project, making it impossible to trace a shift in technical vocabulary over time. What can be said is that within this window their focus was consistently photonics applied to biomedical and neurological imaging — no diversification into other application domains is visible from this data.

Based solely on H2020 data, PicoQuant appears to be moving their instrumentation expertise toward clinical and neurological monitoring applications, though the narrow time window makes this a tentative signal rather than a confirmed trend.

How they like to work

PicoQuant has participated exclusively as a consortium partner, never as coordinator, which is typical of instrumentation SMEs that join training networks to provide industrial exposure rather than to lead scientific programmes. Their presence in two MSCA-ITN-ETN networks — each involving large multi-country academic consortia — suggests they are a valued specialist node rather than a project driver. Working with them likely means accessing their instruments and application expertise in exchange for hosting or co-supervising early-stage researchers.

PicoQuant has built connections with 20 unique consortium partners spread across 7 countries through their two projects, a reasonably broad network for an SME with only two participations. Their reach is European, centered on academic and research institutions working in photonics and life sciences.

What sets them apart

PicoQuant occupies a rare position as a commercial photonics instrumentation company that actively participates in EU training networks — most instrument manufacturers stay outside funded research consortia entirely. This means they combine product-level expertise in TCSPC and pulsed laser systems with genuine experience co-supervising PhD-level research, making them unusually credible as both a technology supplier and a scientific collaborator. For a consortium needing an industrial partner that can contribute real instruments and trained scientists rather than just a logo, PicoQuant is a strong candidate.

Highlights from their portfolio

• BitMap
  Applying photonics to real-time brain injury and trauma monitoring represents a high-stakes clinical translation of PicoQuant's core detection technology, signaling ambition beyond laboratory imaging.
• BE-OPTICAL
  As PicoQuant's first recorded H2020 participation, this biomedical optical imaging network established their model of contributing instrumentation expertise to large multi-national training consortia.